Biomerica, Inc. (BMRA) vs Cardio Diagnostics Holdings, Inc. (CDIO)

A side-by-side comparison of Biomerica, Inc. and Cardio Diagnostics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BMRA vs CDIO

growth of $100 · dividends reinvested · last 5y
BMRA -94.3% (-43.6%/yr)CDIO -99.3% (-62.9%/yr)BMRA compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $1002023202420252026$6$1
BMRA CDIO

BMRA vs CDIO: by the numbers

  • •BMRA is the larger company ($6M vs $6M market cap).
  • •Both run net losses; BMRA's is the smaller (-84.79% vs -44771.83% net margin).

Metrics side by side

Valuation

MetricBMRACDIO
P/S ratio1.42421.90
P/B ratio2.410.82

Profitability

MetricBMRACDIO
Gross margin8.09%100.00%
Operating margin-119.54%-43737.46%
Net margin-84.79%-44771.83%
ROE-143.54%-87.12%
ROIC-117.93%-82.84%

Growth (annualized)

MetricBMRACDIO
Revenue CAGR (5Y)-9.17%N/A
Total return CAGR (5Y)-46.66%N/A

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.